Search results
Results From The WOW.Com Content Network
Alosetron, sold under the brand name Lotronex among others, is a 5-HT 3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in females only. It was patented in 1987 and approved for medical use in 2002. [ 2 ]
The Pharmacy Examining Board of Canada administers the Pharmacy Technician Qualifying Examination. Pharmacy technicians are required to be registered with a provincial or a national regulatory body or council. In provinces and jurisdictions where pharmacy technician is a regulated occupation, liability insurance is required to practice. [7] [8]
The following is a list of organizations for professionals involved in the practice of pharmacy. Such organizations are typically professional societies, as opposed to trade associations . This article contains dynamic lists that may never be able to satisfy particular standards for completeness.
Canada Withdrawn over ... Alosetron (Lotronex) 2000 US Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [2] ... [58] and the United ...
The Pharmacy Examining Board of Canada (PEBC), established by an Act of Parliament in 1963, is the national certification body for the profession of pharmacy in Canada.It currently assesses the qualifications of 2 pharmacy professional candidates seeking licensure - pharmacists and pharmacy technicians, on behalf the pharmacy regulatory authorities (PRAs) of all provinces except Quebec, and ...
Variation by state State Pharmacist-to-pharmacy technician ratio Alabama: 1:3 if one is certified or 1:4 if 2 are certified Alaska: None Arizona: None Arkansas: 1:3 California: 1:1, then two more techs for each additional pharmacist Colorado: 1:6, majority must be certified [2] Connecticut: 1:3 institutional pharmacy, 1:2 community pharmacy ...
CIPA has appeared frequently in the news as an advocate for safe online pharmacy practices and the lower prices of drugs available outside of the United States, [5] [6] though not without significant controversy. [7] [8] CIPA standards and practices have been described as "likely becoming a major part of the health care system in the near ...
The use of a drug of last resort may be based on agreement among members of a patient's care network, including physicians and healthcare professionals across multiple specialties, or on a patient's desire to pursue a particular course of treatment and a practitioner's willingness to administer that course.